Publicaciones en colaboración con investigadores/as de Universitat de València (46)

2024

  1. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 575-586

  2. Current barriers to initiating insulin therapy in individuals with type 2 diabetes

    Frontiers in Endocrinology, Vol. 15

  3. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

  4. The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective

    Patient Preference and Adherence, Vol. 18, pp. 151-164

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  3. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  4. Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells

    Spine Journal, Vol. 23, Núm. 10, pp. 1549-1562

2021

  1. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  2. Time-in-range for monitoring glucose control: Is it time for a change?

    Diabetes Research and Clinical Practice, Vol. 177

  3. Transdiagnostic perspective of impulsivity and compulsivity in obesity: From cognitive profile to self-reported dimensions in clinical samples with and without diabetes

    Nutrients, Vol. 13, Núm. 12

2020

  1. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

    Clinical Epigenetics, Vol. 11, Núm. 1

  2. Associations between neuropsychological performance and appetite-regulating hormones in anorexia nervosa and healthy controls: Ghrelin's putative role as a mediator of decision-making

    Molecular and Cellular Endocrinology, Vol. 497

  3. Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Scientific Reports, Vol. 9, Núm. 1

  4. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants

    International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i

2017

  1. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity

    PLoS ONE, Vol. 12, Núm. 2

  2. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22